W. van Geffen (Leeuwarden, Netherlands), D. Jovanovic (Beograd, Republic of Serbia), J. Domagala-Kulawik (Warszawa, Poland), J. Aerts (Rotterdam, Netherlands)
The role of Radiological follow-up protocol in patients with surgically resected Non-Small Cell Lung Cancer.
R. Salman (Leeds, United Kingdom), J. Robson (Leeds, United Kingdom), T. Quinn (Leeds, United Kingdom)
|   |
Lung Cancer Prevalence after 4 years of screening in a COPD/Emphysema centered screening program
M. Zambrano Chacon (Madrid, Spain), L. Núñez García (Madrid, Spain), C. Gotera Rivera (Madrid, Spain), M. Pérez Warnisher (Madrid, Spain), R. Melchor Iñiguez (Madrid, Spain), E. Pinillos Robles (Madrid, Spain), E. Cabezas Pastor (Madrid, Spain), A. El Hachem Debek (Madrid, Spain), M. Rodríguez Guzmán (Madrid, Spain), P. Lazo Meneses (Madrid, Spain), J. Alfayate Sanchez (Madrid, Spain), N. Mangado (Madrid, Spain), G. Peces-Barba Romero (Madrid, Spain), L. Seijo Maceiras (Madrid, Spain)
| |
Prevalence of bronchiectasis in a lung cancer screnning program
L. Nuñez Garcia (Madrid, Spain), M. Zambrano Chacón (Madrid, Spain), C. Gotera Rivera (Madrid, Spain), T. Pérez Warnisher (Madrid, Spain), R. Melchor Iñiguez (Madrid, Spain), E. Pinillos Robles (Madrid, Spain), E. Cabezas Pastor (Madrid, Spain), A. El Hachem Debek (Madrid, Spain), M. Rodríguez Guzmán (Madrid, Spain), P. Lazo Meneses (Madrid, Spain), J. Alfayate Sánchez (Madrid, Spain), N. González Mangado (Madrid, Spain), G. Peces-Barba Romero (Madrid, Spain), L. Seijo Maceiras (Madrid, Spain)
| |
Risk factors and prognosis of non-solid nodules in a lung cancer screening program
A. Campo Ezquibela (Pamplona, Spain), P. Yuste Olmos (Pamplona, Spain), M. Ocon De Miguel (Pamplona, Spain), A. Alcaide Ocaña (Pamplona, Spain), J. De Torres Tajes (Pamplona, Spain), J. Berto Botella (Pamplona, Spain), J. Pueyo Villoslada (Pamplona, Spain), M. Lozano Escario (Pamplona, Spain), J. Zulueta Francés (Pamplona, Spain)
| |
Determining the perception of lung cancer screening programme amongst medical patients in single tertiary centre.
K. Wei Hao (Kuala Lumpur, Malaysia), A. Ban (Kuala Lumpur, Malaysia), M. Faisal (Kuala Lumpur, Malaysia)
| |
Lung cancer–CT screening performed in a high risk portuguesese population
S. Moura Cabral (Coimbra, Portugal), I. Abreu (Coimbra, Portugal), D. Madama (Coimbra, Portugal), A. Estevão (Coimbra, Portugal), E. Cordeiro (Coimbra, Portugal), J. Pimentel (Coimbra, Portugal), N. Miranda (Coimbra, Portugal), C. Robalo Cordeiro (Coimbra, Portugal)
| |
CT-imaging and pathological analysis of preinvasive lesions and minimally invasive adenocarcinoma presented as pulmonary ground-glass opacity
T. Ma (Changchun, China), Y. Hu (Changchun, China), D. Qu (Changchun, China)
| |
Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer
S. Kort (Enschede, Netherlands), M. Brusse-Keizer (Enschede, Netherlands), H. Schouwink (Enschede, Netherlands), E. Citgez (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands), J. Gerritsen (Zutphen, Netherlands), J. Van Der Palen (Zutphen, Netherlands)
| |
Screening performance of carcinoembryonic antigen and cytokeratin-19 fragment with smoking status adjusted cut-off level in combination with low-dose computed tomography for 2-year lung cancer outcome.
N. Triphuridet (Bangkok, Thailand), S. Vidhyarkorn (Bangkok, Thailand), A. Worakitsitisatorn (Bangkok, Thailand), N. Chuengkhlay (Bangkok, Thailand), W. Krongthong (Bangkok, Thailand), J. Patumanond (Chiang Mai , Thailand), C. Auewarakul (Bangkok, Thailand)
| |
Exploring the role of virtual lung cancer follow-up post-surgical resection.
P. Devlin (Edinburgh, United Kingdom), P. Reid (Edinburgh, United Kingdom)
| |
Lung cancer in never-smokers
B. Tanguy (St Denis, Reunion), M. Tanguy (Nancy, France), B. Tanguy (St Denis, Reunion)
| |
Lung Cancer screening- a need for local adaptation?
F. Easton (Taunton, United Kingdom), A. Yarde (Taunton, United Kingdom), S. Foster (Taunton, United Kingdom), J. Fallon (Taunton, United Kingdom)
| |
CHARACTERISTICS OF SECOND TUMORS AND RECURRENCES IN SURGICALLY TREATED LUNG CANCER
F. Laso Del Hierro (Madrid, Spain), P. Lopez Yeste (Madrid, Spain), M. Mohamed Choukri (Madrid, Spain), A. Izquierdo Perez (Madrid, Spain), J. Corral Cano (Madrid, Spain), J. Zapatero Gaviria (Madrid, Spain), I. Muguruza Trueba (Madrid, Spain), S. Vicente Antunes (Madrid, Spain), F. Villar Alvarez (Madrid, Spain)
| |
Autofluorescence bronchoscopy - role in current clinical practice
V. Cosei (Bucharest, Romania), C. Badescu (Bucharest, Romania), R. Ulmeanu (Bucharest, Romania)
| |
Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study
K. Cholidou (Athens, Greece), N. Anagnostopoulos (Athens, Greece), D. Grapsa (Athens, Greece), I. Gkiozos (Athens, Greece), E. Kokkotou (Athens, Greece), A. Vassias (Athens, Greece), S. Tsagouli (Athens, Greece), P. Bakakos (Athens, Greece), I. Kotteas (Athens, Greece), A. Charpidou (Athens, Greece)
| |
The Burden of Asymptomatic Lung Cancer
S. Hanger (Watford, United Kingdom), C. Haria (Watford, United Kingdom), D. Li (Watford, United Kingdom), R. Mogal (Watford, United Kingdom)
| |
In whom could we diagnose second primary lung cancers ‘early’?
R. Lee (London, United Kingdom), N. Low (London, United Kingdom), S. Popat (London, United Kingdom)
| |
ERS Taskforce harmonised standards for lung cancer (LC) registration in Europe and the current Greek screenshot;Is it a long way to Tipperary?
G. Hardavella (Athens, Greece), G. Metaxas (Athens, Greece), K. Mproupi (Athens, Greece), I. Karampinis (Athens, Greece), I. Kainis (Athens, Greece)
| |
An eleven year analysis of a national heath insurance database on primary lung cancer
J. Magallanes (Manila, Philippines), J. Santiaguel (Manila, Philippines)
| |